Is a complete IDX/CARE research report available?

No complete published report is available for idx/CARE (IDX/CARE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

idx/CARE stock profile: metrics, valuation and analysis

Market cap	13.4T
Revenue (ttm)	493.1B
Net income (ttm)	6B
EPS (ttm)	IDR 0.18
Shares out	33.3B
P/E (trailing)	2227.9x
Volume	606,500
Beta	-0.44

All IDX/CARE indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

IDR

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	866
Employees Change	33%
Employees Change Percent	3.96
Enterprise value	IDR 14T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	71.54
Industry PE Fwd	17.68
Isin	ID1000154909
Last refreshed	2026-09-12
Market cap	IDR 13.4T
Price	IDR 402
Price currency	IDR
Rev Per Employee	569,435,845.03x
Sector	Healthcare
Sector PE	36.03
Sector PE Fwd	13.18
Sic	8060
Symbol	idx/CARE
Website	https://www.metrohealthcareindonesia.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.04%
EV Earnings	2,326.78x
EV/EBIT	150x
EV/EBITDA	116.02x
EV/Sales	28.31x
FCF yield	-1.29%
P/B ratio	4.42x
P/E ratio	2,227.85x
P/S ratio	27.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.87%
EBITDA Margin	24.4%
Gross margin	49.47%
Gross Profit	IDR 243.9B
Gross Profit Growth	76.29%
Gross Profit Growth Q	-12.89%
Gross Profit Growth3 Y	36.44%
Gross Profit Growth5 Y	13.17%
Net Income	IDR 6B
Net Income Growth Q	-92.84%
Net Income Growth Qo Q	1,442.15%
Net Income Growth Years	2%
Net Income Growth5 Y	-24.05%
Pretax Margin	2.12%
Profit Margin	1.22%
Profit Per Employee	IDR 6.9M
Profitable Quarters	IDR 5
Profitable Years	1
ROA	1.44
Roa5y	-0.12
ROCE	2.62
ROE	0.21
Roe5y	-1.73
ROIC	1.56
Roic5y	-0.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.05%
Cagr3y	-7.01%
Cagr5y	-0.87%
EPS Growth Q	-92.84
EPS Growth Qo Q	1,442.3
EPS Growth Years	2
EPS Growth5 Y	-24.83
OCF Growth5 Y	0.89%
Revenue Growth	58.25x
Revenue Growth Q	12.6x
Revenue Growth Qo Q	-24.14x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	24.66x
Revenue Growth5 Y	13.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.12
Assets	IDR 4.2T
Cash	IDR 470.3B
Current Assets	IDR 521.5B
Current Liabilities	IDR 600.8B
Debt	IDR 1.1T
Debt EBITDA	IDR 8.82
Debt Equity	IDR 0.35
Debt FCF	IDR -6.15
Equity	IDR 3T
Interest Coverage	0.95
Liabilities	IDR 1.1T
Long Term Assets	IDR 3.6T
Long Term Liabilities	IDR 529.5B
Net Cash	IDR -591.6B
Net Cash By Market Cap	IDR -4.43
Net Debt EBITDA	IDR 4.92
Net Debt Equity	IDR 0.2
Tangible Book Value	IDR 3T
Tangible Book Value Per Share	IDR 90.96
WACC	2.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	45.09
Net Working Capital	IDR -9.3B
Quick ratio	0.85
Working Capital	IDR -79.3B
Working Capital Turnover	IDR -2.97

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.03%
200-day SMA	450.3
3Y total return	-19.6%
50-day SMA	427.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-4.29%
All Time High	965
All Time High Change	-58.34%
All Time High Date	2026-01-23
All Time Low	56
All Time Low Change	617.86%
All Time Low Date	2024-06-03
ATR	17.16
Beta	-0.44
Beta1y	-0.11
Beta2y	-0.09
Ch YTD	-40.88
High	414
High52	965
High52 Date	2026-01-23
High52ch	-58.34%
Low	394
Low52	274
Low52 Date	2025-09-26
Low52ch	46.72%
Ma50ch	-6.01%
Price vs 200-day SMA	-10.72%
RSI	31.72
RSI Monthly	54.02
RSI Weekly	45.54
Sharpe ratio	0.83x
Sharpe Ratio3y	0.2x
Sharpe Ratio5y	0.26x
Sortino ratio	1.46
Sortino Ratio3y	0.36
Sortino Ratio5y	0.47
Tr YTD	-40.88
Tr1m	-5.19%
Tr1w	-11.84%
Tr3m	-0.99%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,650,000,001%
Net Borrowing	249,731,374,969
Shares Institutions	17.32%
Shares Out	33,250,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	708,925x
Bv Per Share	90.96
CAPEX	IDR -212.5B
Ch1m	-5.19
Ch1w	-11.84
Ch1y	28.03
Ch3m	-0.99
Ch3y	-19.6
Ch5y	-4.29
Ch6m	-0.5
Change	-1.47%
Change From Open	-0.99
Close	408
Days Gap	-0.49
Depreciation Amortization	27,260,683,669
Dollar Volume	243,813,000
Earnings Date	2026-09-15
EBIT	IDR 93.1B
EBITDA	IDR 120.3B
EPS	IDR 0.18
F Score	7
FCF	IDR -172.8B
FCF EV Yield	-1.24x
FCF Per Share	IDR -5.2
Financing CF	253,156,606,186
Fiscal Year End	December
Founded	2,015
Graham Number	19.21678
Graham Upside	-95.22
Income Tax	IDR 4.1B
Investing CF	-332,495,864,823
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2026-06-30
Lynch Fair Value	IDR 0.9
Lynch Upside	-99.78
Ma150	438.4
Ma150ch	-8.3%
Ma20	432.5
Ma20ch	-7.05%
Net CF	-39,584,989,944
Next Earnings Date	2026-09-15
Open	406
P OCF Ratio	336.2
Position In Range	40
Ppne	3,264,785,854,132
Price Date	2026-09-11
Price EBITDA	IDR 111
Ptbv Ratio	4.42
Relative Volume	0.89x
Revenue	493,131,441,794x
Tax By Revenue	0.83x
Tax Rate	39.25%
Tr6m	-0.5%
Volume	606,500
Z Score	7

IDX/CARE (IDX/CARE)

Price

Financial snapshot

Fair-value bridge

Latest news · IDX/CARE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IDX/CARE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on IDX/CARE

Frequently asked questions